Cargando…
Redefining face contour with a novel anti-aging cosmetic product: an open-label, prospective clinical study
BACKGROUND: Skin aging is accelerated by multiple extrinsic factors: ultraviolet radiation, smoking and pollution increase oxidative activity, damaging cellular and extracellular components such as DNA, proteins, and lipids. With age, collagen and hyaluronic acid levels decline, resulting in loss of...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5691901/ https://www.ncbi.nlm.nih.gov/pubmed/29180884 http://dx.doi.org/10.2147/CCID.S148597 |
_version_ | 1783279884774146048 |
---|---|
author | Garre, Aurora Martinez-Masana, Gemma Piquero-Casals, Jaime Granger, Corinne |
author_facet | Garre, Aurora Martinez-Masana, Gemma Piquero-Casals, Jaime Granger, Corinne |
author_sort | Garre, Aurora |
collection | PubMed |
description | BACKGROUND: Skin aging is accelerated by multiple extrinsic factors: ultraviolet radiation, smoking and pollution increase oxidative activity, damaging cellular and extracellular components such as DNA, proteins, and lipids. With age, collagen and hyaluronic acid levels decline, resulting in loss of elasticity and moisture of the skin. Over time this damage leads to characteristic signs that make the skin look older: altered facial contour, sagging skin, wrinkles, and an uneven complexion. This study evaluated the anti-aging effects of a new facial cream formulated with carnosine, Alteromonas ferment extract, crosspolymer hyaluronic acid, and a tripeptide. METHODS: An open-label intra-individual study to assess the anti-aging efficacy of the investigational product in 33 women aged 45 to 65 years. The product was applied twice daily for 56 days. Facial contour and skin deformation, elasticity, hydration, and complexion were measured with specialized equipment at baseline and days 28 and 56. Additionally, subjects completed questionnaires at days 28 and 56 on the perceived efficacy and cosmetic characteristics of the product. RESULTS: After 56 days of use of the investigational product, a redefining effect was observed, with a significant decrease in sagging jawline (7%). Skin was significantly more hydrated (12%), firmer (29%), and more elastic (20%) (P<0.001 for all). On complexion assessment, skin texture (a measure of skin smoothness) and spots (brown and red skin lesions) also improved significantly (12% and 6% decrease, respectively). In the subjective self-evaluation, the majority of subjects reported that the skin was visibly tightened and more elastic, flexible, and moisturized (91%, 88%, 91%, and 90%, respectively). The product was well tolerated with no adverse events reported during the study. CONCLUSION: This new cosmetic product demonstrated anti-aging effects after 56 days of use, most notably a redefined facial contour and improved complexion. It is a safe and effective anti-aging product. |
format | Online Article Text |
id | pubmed-5691901 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-56919012017-11-27 Redefining face contour with a novel anti-aging cosmetic product: an open-label, prospective clinical study Garre, Aurora Martinez-Masana, Gemma Piquero-Casals, Jaime Granger, Corinne Clin Cosmet Investig Dermatol Original Research BACKGROUND: Skin aging is accelerated by multiple extrinsic factors: ultraviolet radiation, smoking and pollution increase oxidative activity, damaging cellular and extracellular components such as DNA, proteins, and lipids. With age, collagen and hyaluronic acid levels decline, resulting in loss of elasticity and moisture of the skin. Over time this damage leads to characteristic signs that make the skin look older: altered facial contour, sagging skin, wrinkles, and an uneven complexion. This study evaluated the anti-aging effects of a new facial cream formulated with carnosine, Alteromonas ferment extract, crosspolymer hyaluronic acid, and a tripeptide. METHODS: An open-label intra-individual study to assess the anti-aging efficacy of the investigational product in 33 women aged 45 to 65 years. The product was applied twice daily for 56 days. Facial contour and skin deformation, elasticity, hydration, and complexion were measured with specialized equipment at baseline and days 28 and 56. Additionally, subjects completed questionnaires at days 28 and 56 on the perceived efficacy and cosmetic characteristics of the product. RESULTS: After 56 days of use of the investigational product, a redefining effect was observed, with a significant decrease in sagging jawline (7%). Skin was significantly more hydrated (12%), firmer (29%), and more elastic (20%) (P<0.001 for all). On complexion assessment, skin texture (a measure of skin smoothness) and spots (brown and red skin lesions) also improved significantly (12% and 6% decrease, respectively). In the subjective self-evaluation, the majority of subjects reported that the skin was visibly tightened and more elastic, flexible, and moisturized (91%, 88%, 91%, and 90%, respectively). The product was well tolerated with no adverse events reported during the study. CONCLUSION: This new cosmetic product demonstrated anti-aging effects after 56 days of use, most notably a redefined facial contour and improved complexion. It is a safe and effective anti-aging product. Dove Medical Press 2017-11-13 /pmc/articles/PMC5691901/ /pubmed/29180884 http://dx.doi.org/10.2147/CCID.S148597 Text en © 2017 Garre et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. |
spellingShingle | Original Research Garre, Aurora Martinez-Masana, Gemma Piquero-Casals, Jaime Granger, Corinne Redefining face contour with a novel anti-aging cosmetic product: an open-label, prospective clinical study |
title | Redefining face contour with a novel anti-aging cosmetic product: an open-label, prospective clinical study |
title_full | Redefining face contour with a novel anti-aging cosmetic product: an open-label, prospective clinical study |
title_fullStr | Redefining face contour with a novel anti-aging cosmetic product: an open-label, prospective clinical study |
title_full_unstemmed | Redefining face contour with a novel anti-aging cosmetic product: an open-label, prospective clinical study |
title_short | Redefining face contour with a novel anti-aging cosmetic product: an open-label, prospective clinical study |
title_sort | redefining face contour with a novel anti-aging cosmetic product: an open-label, prospective clinical study |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5691901/ https://www.ncbi.nlm.nih.gov/pubmed/29180884 http://dx.doi.org/10.2147/CCID.S148597 |
work_keys_str_mv | AT garreaurora redefiningfacecontourwithanovelantiagingcosmeticproductanopenlabelprospectiveclinicalstudy AT martinezmasanagemma redefiningfacecontourwithanovelantiagingcosmeticproductanopenlabelprospectiveclinicalstudy AT piquerocasalsjaime redefiningfacecontourwithanovelantiagingcosmeticproductanopenlabelprospectiveclinicalstudy AT grangercorinne redefiningfacecontourwithanovelantiagingcosmeticproductanopenlabelprospectiveclinicalstudy |